Chongbin Zhong

453 total citations
18 papers, 338 citations indexed

About

Chongbin Zhong is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Chongbin Zhong has authored 18 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Chongbin Zhong's work include Cardiac Ischemia and Reperfusion (4 papers), Chemotherapy-induced cardiotoxicity and mitigation (4 papers) and Cardiovascular Function and Risk Factors (3 papers). Chongbin Zhong is often cited by papers focused on Cardiac Ischemia and Reperfusion (4 papers), Chemotherapy-induced cardiotoxicity and mitigation (4 papers) and Cardiovascular Function and Risk Factors (3 papers). Chongbin Zhong collaborates with scholars based in China. Chongbin Zhong's co-authors include Yanjun Song, Xianbao Wang, Pingzhen Yang, Wei Wu, Xudong Song, Deshu Chen, Yanbin Cai, Jiejing Li, Xu Liao and Jie Zhan and has published in prestigious journals such as Acta Biomaterialia, Journal of Cellular Physiology and The Journal of Pathology.

In The Last Decade

Chongbin Zhong

17 papers receiving 338 citations

Peers

Chongbin Zhong
Chongbin Zhong
Citations per year, relative to Chongbin Zhong Chongbin Zhong (= 1×) peers Yingqiang Du

Countries citing papers authored by Chongbin Zhong

Since Specialization
Citations

This map shows the geographic impact of Chongbin Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chongbin Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chongbin Zhong more than expected).

Fields of papers citing papers by Chongbin Zhong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chongbin Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chongbin Zhong. The network helps show where Chongbin Zhong may publish in the future.

Co-authorship network of co-authors of Chongbin Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Chongbin Zhong. A scholar is included among the top collaborators of Chongbin Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chongbin Zhong. Chongbin Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Liao, Xu, Min Tang, Jiejing Li, et al.. (2025). Acid‐Triggered Cascaded Responsive Supramolecular Peptide Alleviates Myocardial Ischemia‒Reperfusion Injury by Restoring Redox Homeostasis and Protecting Mitochondrial Function. Advanced Healthcare Materials. 14(7). e2404319–e2404319. 3 indexed citations
2.
Li, Jingchao, Fengjiao Liu, Xu Liao, et al.. (2025). Erythrocyte Membrane-Camouflaged Xanthohumol Nanoparticles Mitigate Doxorubicin-Induced Cardiotoxicity by Inhibiting Ferroptosis. ACS Biomaterials Science & Engineering. 11(5). 2727–2738. 2 indexed citations
3.
Zhong, Chongbin, et al.. (2024). The activation of LBH-CRYAB signaling promotes cardiac protection against I/R injury by inhibiting apoptosis and ferroptosis. iScience. 27(5). 109510–109510. 4 indexed citations
4.
Zhong, Chongbin, et al.. (2024). Causal roles of immune cells in cardiovascular diseases: A Mendelian randomization (MR) study. PubMed. 13. 4086371297–4086371297.
5.
Mo, Hongwei, Wenjie Yu, Xuwei Zhang, et al.. (2024). eEF2K alleviates doxorubicin-induced cardiotoxicity by inhibiting GSK3β and improving autophagy dysfunction. Cell Biology and Toxicology. 41(1). 15–15. 2 indexed citations
6.
Li, Yang, Shen Luo, Jing Yan, et al.. (2023). Angiotensin IV ameliorates doxorubicin-induced cardiotoxicity by increasing glutathione peroxidase 4 and alleviating ferroptosis. Toxicology and Applied Pharmacology. 479. 116713–116713. 7 indexed citations
7.
Yan, Jing, Zehua Li, Chaobo Yang, et al.. (2023). Fucoxanthin alleviated myocardial ischemia and reperfusion injury through inhibition of ferroptosis via the NRF2 signaling pathway. Food & Function. 14(22). 10052–10068. 38 indexed citations
8.
Zhong, Chongbin, Wenjie Yu, Deshu Chen, et al.. (2023). Amine oxidase copper‐containing 3 aggravates cardiac remodelling by generating hydrogen peroxide after myocardial infarction. The Journal of Pathology. 260(2). 190–202. 6 indexed citations
9.
Zhong, Chongbin, et al.. (2022). Trimethylamine-N-oxide (TMAO) promotes balloon injury-induced neointimal hyperplasia via upregulating Beclin1 and impairing autophagic flux. Biomedicine & Pharmacotherapy. 155. 113639–113639. 6 indexed citations
10.
Chen, Deshu, Wenjie Yu, Chongbin Zhong, et al.. (2022). Elabela ameliorates doxorubicin-induced cardiotoxicity by promoting autophagic flux through TFEB pathway. Pharmacological Research. 178. 106186–106186. 51 indexed citations
11.
Liao, Xu, Xudong Song, Jiejing Li, et al.. (2022). An injectable co-assembled hydrogel blocks reactive oxygen species and inflammation cycle resisting myocardial ischemia-reperfusion injury. Acta Biomaterialia. 149. 82–95. 63 indexed citations
12.
Zheng, Huajun, Chongbin Zhong, Hekai Li, et al.. (2021). Nkx2‐3 induces autophagy inhibiting proliferation and migration of vascular smooth muscle cells via AMPK/mTOR signaling pathway. Journal of Cellular Physiology. 236(11). 7342–7355. 13 indexed citations
13.
Song, Yanjun, Chongbin Zhong, & Wei Wu. (2020). Cardioprotective effects of melatonin: Focusing on its roles against diabetic cardiomyopathy. Biomedicine & Pharmacotherapy. 128. 110260–110260. 23 indexed citations
14.
Song, Yanjun, Chongbin Zhong, & Wei Wu. (2020). Resveratrol and Diabetic Cardiomyopathy: Focusing on the Protective Signaling Mechanisms. Oxidative Medicine and Cellular Longevity. 2020. 1–19. 25 indexed citations
15.
Liu, Yong, Han Shen, Liu Zu, et al.. (2020). Nkx2–5 Regulates the Proliferation and Migration of H9c2 Cells. Medical Science Monitor. 26. e925388–e925388. 6 indexed citations
16.
Song, Yanjun, Chongbin Zhong, & Xianbao Wang. (2018). Heat shock protein 70: A promising therapeutic target for myocardial ischemia–reperfusion injury. Journal of Cellular Physiology. 234(2). 1190–1207. 53 indexed citations
17.
Zhong, Chongbin, et al.. (2017). The Role of Peroxisome Proliferator-Activated Receptor γ in Mediating Cardioprotection Against Ischemia/Reperfusion Injury. Journal of Cardiovascular Pharmacology and Therapeutics. 23(1). 46–56. 24 indexed citations
18.
Zhu, Xiao‐Yong, et al.. (1993). Streptozotocin induced cardiomyopathy in diabetic rats.. PubMed. 106(6). 463–6. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026